| |
original article |
Journal |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
Australian Prescriber |
2022―Oct―12 |
New drug: Elasomeran/imelasomeran for prevention of COVID-19 |
|
| 2 |
[GO] |
Australian Prescriber |
2022―Aug―31 |
New drug: Tixagevimab and cilgavimab for COVID-19 prophylaxis |
|
| 3 |
[GO] |
Australian Prescriber |
2022―Mar―23 |
Editorial: Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum? |
Ian D Coombes, Amy Legg, Tina Petterson, Tanya Kelly, Andrew Henderson, Jason A Roberts |
| 4 |
[GO] |
Australian Prescriber |
2022―Feb―26 |
New drug: Nirmatrelvir and ritonavir for COVID-19 |
|
| 5 |
[GO] |
Australian Prescriber |
2022―Feb―26 |
New drug: Molnupiravir for COVID-19 |
|
| 6 |
[GO] |
Australian Prescriber |
2022―Feb―26 |
New drug: Casirivimab and imdevimab for COVID-19 |
|
| 7 |
[GO] |
Australian Prescriber |
2022―Feb―26 |
New drug: SARS-CoV-2 rS (NVX-CoV-2373) vaccine for prevention of COVID-19 |
|
| 8 |
[GO] |
Australian Prescriber |
2021―Sep―28 |
New drug: Sotrovimab for COVID-19 |
|
| 9 |
[GO] |
Australian Prescriber |
2021―Sep―06 |
New drug: Elasomeran for prevention of COVID-19 |
|
| 10 |
[GO] |
Australian Prescriber |
2021―Mar―09 |
New drug: ChAdOx1-S vaccine for prevention of COVID-19 |
|
| 11 |
[GO] |
Australian Prescriber |
2021―Feb―26 |
Letter to the Editor: Evolving evidence for immunosuppressants in COVID-19 |
Ajay K Shukla, Senthuran Shivakumar, Olivia C Smibert, Jason A Trubiano, Albert G Frauman, David FL Lliew |
| 12 |
[GO] |
Australian Prescriber |
2021―Feb―25 |
New drug: BNT162b2 vaccine for prevention of COVID-19 |
|
| 13 |
[GO] |
Australian Prescriber |
2020―Dec―16 |
COVID-19 vaccines - are we there yet? |
Peter McIntyre, Ye Jin Joo, Clayton Chiu, Katie Flanagan, Kristine Macartney |
| 14 |
[GO] |
Australian Prescriber |
2020―Oct―14 |
Diagnostic Tests: Testing for COVID-19 |
|
| 15 |
[GO] |
Australian Prescriber |
2020―Aug―18 |
New Drug: Remdesivir for COVID-19 |
|
| 16 |
[GO] |
Australian Prescriber |
2020―Aug―18 |
Management of autoimmune disease during the COVID-19 pandemic |
Philip C Robinson, Evan C Bursle |
| 17 |
[GO] |
Australian Prescriber |
2020―Jul―31 |
Letter to the Editor: QUM and COVID-19 in young adults |
Manjiri Gharat, Darren M Roberts, Alexandra Bennett |
| 18 |
[GO] |
Australian Prescriber |
2020―Jun―16 |
Editorial: Immunosuppression for COVID-19: repurposing medicines in a pandemic |
Senthuran Shivakumar, Olivia C Smibert, Jason A Trubiano, Albert G Frauman, David FL Liew |
| 19 |
[GO] |
Australian Prescriber |
2020―May―07 |
Editorial: COVID-19 and the quality use of medicines: evidence, risks and fads |
Darren M Roberts, Alexandra Bennett |
| 20 |
[GO] |
Australian Prescriber |
2020―Apr―21 |
Editorial: Principles of ethial prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic |
Ian Coombes, Alexandra Markwell, Paul Kubler, Andrew M Redmond, Gordon McGurk, Jason A Roberts |
